Abbott tells CES it’s getting into consumer biowearables

DMCA / Correction Notice
- Advertisement -

American medical device manufacturer, Abbott, is leading the way in making general-purpose consumer biosensing wearables.

- Advertisement -

The company has been making continuous glucose monitor (CGM) hardware for diabetes management for years (since 2014) — but at a HealthTech keynote at CES yesterday, Abbott’s President and CEO, Robert B. is developing a new line of linguine — called lingo — intended for more general fitness and wellness purposes.

“Technology gives us the power to digitize, decentralize and democratize healthcare, create a common language between you and your doctor, and have more control over your health,” he said as the keynote speaker. “We are building a future that will provide more personalized and accurate care to you and your loved ones. It is happening right now. And its potential is nothing short of incredible.”


Ford said the lingo-sensing technology is being designed to track “key signals” in the body — such as glucose, ketones and lactate — adding that it could also be used to track alcohol levels in the future. can be done.

Last year the company launched a biosensor designed for athletes—called the Libre Sense Glucose Sport BioWarable—which was made available in Europe, and was used to support the training needs of marathon world record holder Iliad Kipchoge. has been done.

- Advertisement -

Abbott explains his goal with the lingo The goal is to expand glucose monitoring to help people manage their weight, sleep better, improve energy, and think clearly.

To support this expanded utility, it said it is developing biosensors to measure biomarkers other than glucose.

The company said in a press release, “A ketone bioavailable is being developed to continuously track ketones, see how fast you’re getting into ketosis, and understand how you can get there by providing insights on dieting and weight loss.” What holds.” “A lactate biovariable is in development to track continuous lactate build-up during exercise, which can be used as an indicator of athletic performance.”

In recent years a number of startups in the US, Europe and Asia have been seeking to produce CGM hardware – including existing sensors made by Abbott – for various non-medical purposes, with real-time blood pressure targeted at fitness enthusiasts. Launching of glucose tracking services, people wanting to lose weight or health conscious consumers in general.

Abbott jumps into the space so quickly that it sees significant potential for biosensing consumer wearables to go mainstream.

For a deep dive on what it’s like to live with a CGM biosensor attached to your arm – and the constantly updated window into the biological process that it provides – check out Nerdshala’s review of Ultrahuman’s cyborg service, an Indian -based startup that is reproducing current-gen sensing hardware manufactured by Abbott.

- Advertisement -

Stay on top - Get the daily news in your inbox

Recent Articles

Related Stories